NCT04898088View on ClinicalTrials.gov

A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

September 30, 2020

Conditions
COVID-19 Pneumonia
Interventions
BIOLOGICAL

Mesenchymal Stem Cells Transplantation

Mesenchymal Stem Cells Transplantation applied as three intravenous infusions with 30 days intervals

Trial Locations (2)

34010

Istinye University, Istanbul

34147

SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul

All Listed Sponsors
collaborator

Istinye University

OTHER

collaborator

Liv Hospital (Ulus)

UNKNOWN

lead

SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi

OTHER

NCT04898088 - A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients | Biotech Hunter | Biotech Hunter